Literature DB >> 6662747

Adjuvant therapy for Dukes C adenocarcinoma of colon.

H J Brenner, C Bibi, S Chaitchik.   

Abstract

Forty-two patients with adenocarcinoma of the colon, who received surgery between 1975 and 1978 and were to found to have pericolonic fat infiltration and lymph node metastases, were analyzed for disease free period and overall survival. Twenty-one patients had received post-operative X ray therapy, and post-X ray therapy intravenous 5-Fluorouracil adjuvant therapy. Twenty-one patients, matched by age, sex, ethnic origin and site of disease were untreated. The 5 year survival rate for the treated group was 65% compared with 36% for the control group (P greater than 0.2). At 5 years 55% of the treated group were disease free but only 12% of the control group remained disease free (P = 0.04). The significance of this work needs to be established by a randomized and prospectively controlled clinical trial.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662747     DOI: 10.1016/0360-3016(83)90346-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Adjuvant treatment in colorectal cancer: an update.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

2.  Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum.

Authors:  W M Mendenhall; R R Million; K I Bland; W W Pfaff; E M Copeland
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

3.  Adjuvant postoperative radiation therapy for colonic carcinoma.

Authors:  C G Willett; J E Tepper; S J Skates; W C Wood; E C Orlow; J R Duttenhaver
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

4.  Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient.

Authors:  Luca Boldrini; Angela Romano; Lorenzo Placidi; Gian Carlo Mattiucci; Giuditta Chiloiro; Davide Cusumano; Veronica Pollutri; Marco Valerio Antonelli; Luca Indovina; Maria Antonietta Gambacorta; Vincenzo Valentini
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.